Ординатура / Офтальмология / Английские материалы / Electrophysiology of Vision_Lam_2005

63.Spadea L, Bianco G, Dragani T, Balestrazzi E. Early detection of P-VEP and PERG changes in ophthalmic Graves’ disease. Graefes Arch Clin Exp Ophthalmol 1997; 235:501–505.

64.Bobak P, Friedman R, Brigell M, Goodwin J, Anderson R. Visual evoked potentials to multiple temporal frequencies. Use in the differential diagnosis of optic neuropathy. Arch Ophthalmol 1988; 106:936–940.

65.Gotoh Y, Machida S, Tazawa Y. Selective loss of the photopic negative response in patients with optic nerve atrophy. Arch Ophthalmol 2004; 122:341–346.

66.Salvi M, Spaggiari, E, Neri F, Maculuso C, Gardini B, Ferrozzi F, Minelli R, Wall JR, Roti E. The study of visual evoked potentials in patients with thyroid-associated ophthalmopathy identifies asymptomatic optic nerve involvement. J Clin Endocrinol Metab 1997; 82:1027–1030.

67.Setala K, Raitta C, Valimake M, Katevuo V, Lamberg B-A. The value of visual evoked potentials in optic neuropathy of Graves’ disease. J Endocrinol Invest 1992; 15:821–826.

68.Tsaloumas MD, Good PA, Burdon MA, Misson GP. Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy. Eye 1994; 8:638–645.

69.Ambrosio G, Ferrara G, Vitale R, De Marco R. Visual evoked potentials in patients with Graves’ ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Doc Ophthalmol 2003; 106:99–104.

70.Parmar DN, Sofat A, Bowman R, Bartlett JR, Holder GE. Visual prognostic value of the pattern electroretinogram in chiasmal compression. Br J Ophthalmol 2000; 84:1024–1026.

71.Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The International Optic Nerve Trauma Study Group. The treatment of traumatic optic neuropathy. Ophthalmology 1999; 106: 1268–1277.

72.Abraham FA, Spierer A, Blumenthal M. Optic nerve trauma with prolonged blindness followed by visual-evoked potential. Ophthalmologica 1987; 194:40–43.

73.Fuller DG, Hutton WL. Prediction of postoperative vision in eyes with severe trauma. Retina 1990; 10:520–534.

74.Mahapatra AK. Visual evoked potentials in optic nerve injury—does it merit to be mentioned. Ind J Ophthalmol 1991; 39:20–21.

75.Tandon DA, Thakar A, Mahapatra AK, Ghosh P. Transethmoidal optic nerve decompression. Clin Otolaryngol 1994; 19:98–104.

76.Cornelius CP, Altenmuller E, Ehrenfeld M. The use of flash visual evoked potentials in the early diagnosis of suspected optic nerve lesions due to craniofacial trauma. J Craniomaxillofac Surg 1996; 24:1–11.

77.Mashima Y, Oguchi Y. Clinical study of the pattern electroretinogram in patients with optic nerve damage. Doc Ophthalmol 1985; 61:91–96.

78.Scholl GB, Song HS, Winkler DE, Wray SH. The pattern visual evoked potential and pattern electroretinogram in dru- sen-associated optic neuropathy. Arch Ophthalmol 1992; 110:75–81.

79.Mustonon E, Sulg I, Kallanranta T. Electroretinogram (ERG) and visual evoked response (VER) studies in patients with optci disc drusen. Acta Ophthalmol (Copenh) 1980; 58: 539–549.

80.Vieregge P, Rosengart A, Mehdorn E, Wessel K, Kompf D. [Drusen papilla with vision disorder and pathologic visual evoked potentials]. Nervenarzt 1990; 61:364–368.

81.Shibata K, Shibagaki Y, Nagal C, Iwata M. Visual evoked potentials and electro retinograms in an early stage of Leber’s hereditary optic neuropathy. J Neurol 1999; 246:847–849.

82.Nikoskelainen E, Sogg RL, Rosenthal AR, Friberg TR, Dorfman LJ. The early phase in Leber hereditary optic atrophy. Arch Ophthalmol 1977; 95:969–978.

83.Livingstone IR, Mastaglia FL, Howe JW, Aherne GE. Leber’s optic neuropathy: clinical and visual evoked response studies in asymptomatic and symptomatic members of a 4-generation family. Br J Ophthalmol 1980; 64:751–757.

84.Carroll WM, Mastaglia FL. Leber’s optic neuropathy: a clinical and visual evoked potential study of affected and asymp-

tomatic members of a six generation family. Brain 1979; 102:559–580.

85.Mondelli M, Rossi A, Scarpini C, Dotti MT, Federico A. Leber’s optic atrophy: VEP and BAEP changes in 16 asymptomatic subjects. Acta Neurol Scand 1991; 84:366.

86.Berninger TA, Jaeger W, Krastel H. Electrophysiology and colour perimetry in dominant infantile optic atrophy. Br J Ophthalmol 1991; 75:49–52.

87.Holder GE, Votruba M, Carter AC, Bhattacharya SS, Fitzke FW, Moore AT. Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28–qter. Doc Ophthalmol 1998–1999; 95:217–228.

88.Votruba M, Fitzke FW, Holder GE, Carter AC, Bhattacharya SS, Moore AT. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 1998; 116:351–358.

89.Harding GF, Crews SJ, Pitts SM. Psychophysical and visual evoked potential findings in hereditary optic atrophy. Trans Ophthalmol Soc UK 1979; 99:96–102.

90.Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol 1979; 97:1680–1686.

91.Good WV, Jan JE, DeSa L, Barkovich J, Groenveld M, Hoyt CS. Cortical visual impairment in children. Surv Ophthalmol 1994; 38:351–364.

92.Crighel E, Botex MI. Photopic evoked potentials in man in lesions of the occipital lobe. Brain 1966; 69:311–316.

93.Kooi KA, Sharbtough FW. Electrophysiological findings in cortical blindness. Electroencephalogr Clin Neurophysiol 1966; 2:260–263.

94.Abraham FA, Melamed E, Levy S. Prognostic value of visual evoked potentials in occipital blindness following basilar artery occlusion. Appl Neurophysiol 1975; 38:126–135.

95.Duchoway MS, Weiss IP, Majlessi H, Barnet AB. Visual evoked response in childhood cortical blindness after head trauma and meningitis. A longitudinal study of six cases. Neurology 1974; 24:933–940.

96.Kupersmith MJ, Nelson JI. Preserved visual evoked potential in infancy cortical blindness relationship to blindsight. Neuro-Ophthalmol 1986; 6:685–694.

97.Good WV. Development of a quantitative method to measure vision in children with chronic cortical visual impairment. Trans Am Ophthalmol Soc 2001; 99:253–269.

98.Frank Y, Torres F. Visual evoked potentials in the evaluation of ‘‘cortical blindness’’ in children. Ann Neurol 1979; 6: 126–129.

99.Barnet AB, Manson JI, Wilner E. Acute cerebral blindness in childhood. Neurology 1970; 20:1147–1156.

100.Bodis-Wollner I, Atkin A, Raab E, Wolkstein M. Visual association cortex and vision in man: pattern-evoked occipital potentials in a blind boy. Science 1977; 198:629–631.

101.Abe T, Abe K, Aoki M, Itojama Y, Tamai M. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch Ophthalmol 1997; 115:231–236.

102.Drack AV, Traboulsi EI, Maumenee IH. Progression of retinopathy in olivopontocerebellar atrophy with retinal degeneration. Arch Ophthalmol 1992; 110:712–713.

103.Traboulsi EI, Maumenee IH, Green WR, Freimer ML, Moser H. Olivopontocerebellar atrophy with retinal degeneration. A clinical and ocular histopathologic study. Arch Ophthalmol 1988; 106:801–806.

104.Gouw LG, Kaplan CD, Haines JH, Digre KB, Rutledge SL,

˜

Matilla A, Leppert M, Zoghbi HY, PtAcek LJ. Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nat Genet 1995; 10:89–93.

105.Abe T, Tsuda T, Yoshida M, Wada Y, Kano T, itoyama Y, Tamai M. Macular degeneration associated with aberrant expansion of trinucleotide repeat of the SCA7 gene in 2 Japanese families. Arch Ophthalmol 2000; 118:1415–1421.

106.To KW, Adamian M, Jakobiec FA, Berson EL. Olivopontocerebellar atrophy with retinal degeneration. An electroretinographic and histophatologic investigation. Ophthalmology 1993; 100:15–23.

107.Perretti A, Santoro L, Lanzillo B, Filla A, De Michele G, Barbieri F, Martino G, Ragno M, Cocozza S, Caruso G. Autosomal dominant cerebellar ataxia type 1: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients. J Neurol Sci 1996; 142:45–53.

108.Carroll WM, Kriss A, Baraitser M, Barrett G, Halliday AM. The incidence and nature of visual pathway involvement in Friedreich’s ataxia. A clinical and visual evoked potential study of 22 patients. Brain 1980; 103:413–434.

109.Pelosi L, Fels A, Petrillo A, Senatore R, Russo G, Lonegren K, Calace P, Caruso G. Friedreich’s ataxia: clinical involvement and evoked potentials. Acta Neurol Scand 1984; 70:360–368.

110.Alzheimer A. Ueber eiene eigenartige Erkrankung der Himrinede. Allg Z Psychiat Med 1907; 64:146–148.

111.Sadun AA, Borchert M, DeVita E, Hinton DR, Bassi CJ. Assessment of visual impairment in patients with Alzheimer’s disease. Am J Ophthalmol 1987; 104:113–120.

112.Kergoat H, Kergoat MJ, Justino L, Chertkow H, Robillard A, Bergman H. Visual retinocortical function in dementia of the Alzheimer type. Gerontology 2002; 28:197–203.

113.Rizzo J, III, Cronin-Golomb A, Growdon JH, Corkin S, Rosen T, Sandberg MA, Chiappa KH, Lessell S. Retinocalcarine function in Alzheimer’s disease. A clinical and electrophysiological study. Arch Neurol 1992; 49:92–101.

114.Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med 1986; 315:485–487.

115.Curcio CA, Drucker DN. Retinal ganglion cells in Alzheimer’s disease and aging. Ann Neurol 1993; 33:248–257.

116.Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer’s diseae patients. Clin Neurophysiol 2001; 112:1860–1867.

117.Strenn K, Dal-Bianco P, Weghaupt H, Koch G, Vass C, Gottlob I. Pattern electroretinogram and luminanace electroretinogram in Alzheimer’s disease. J Neural Transm Suppl 1991; 33:73–80.

118.Trick GL, Barris MC, Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol 1989; 26:226–331.

119.Prager TC, Schweitzer FC, Peacock LW, Garcia CA. The effect of optical defocus on the pattern electroretinogram in normal subjects and patients with Alzheimer’s disease. Am J Ophthalmol 1993; 116:363–369.

120.Nesher R, Trick GL. The pattern electroretinogram in retinal and optic nerve disease. A quantitative comparison of the pattern of visual dysfunction. Doc Ophthalmol 1991; 77:225–235.

121.Philpot MP, Amin D, Levy R. Visual evoked potentials in Alzheimer’s disease: correlations with age and severity. Electroencephalogr Clin Neurophysiol 1990; 77:323–329.

122.Wright CE, Harding GF, Orwin A. The flash and pattern VEP as a diagnostic indicator dementia. Doc Ophthalmol 1986; 62:89–96.

123.Visser SL, Van Tilburg W, Hooijer C, Jonker C, De Rijke W. Visual evoked potentials (VEPs) in senile dementia (Alzheimer type) and in non-organic behavioural disorders in the elderly: comparison with EEG parameters. Electroencephalogr Clin Neurophysiol 1985; 60:115–121.

124.Haupt WF, Dietz E, Mielke R, Kessler J. Visual evoked potentials in Alzheimer’s disease: investigations in a PETdefined collective. Int J Neurosci 1994; 79:59–66.

125.Celesia GG, Villa AE, Brigell M, Rubboli G, Bolcioni G, Fiori MG. An electrophysiologic study of visual processing in Alzheimer’s disease. Electroencephalogr Clin Neurophysiol 1993; 87:97–104.

126.Ellis CJK, Allen TG, Marsden CD, Ikeda H. Electroretinographic abnormalities in idiopathic Parkinson’s disease and the effect of levodopa administration. Clin Vision Sci 1987; 1:347–355.

127.Jaffe MJ, Bruno G, Campbell G, Lavine RA, Karson CN, Weinberger DR. Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effect of levodopa intravenous infusion. J Neurol Neurosurg Psychiatry 1987; 50:847–852.

128.Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Vision Res 1994; 34: 2629–2638.

129.Peppe A, Stanzione P, Pierelli F, De Angelis D, Pierantozzi M, Bernardi G. Visual alterations in de novo Parkinson’s disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 1995; 45:1144–1148.

130.Bandini R, Pierantozzi M, Bodis-Wollner I. Parkinson’s disease changes the balance of onset and offset visual responses: an evoked potential study. Clin Neurophysiol 2001; 112: 976–983.

131.Buttner T, Kuhn W, Muller T, Heinze T, Puhl C, Przuntek H. Chromatic and achromatic visual evoked potentials in Parkinson’s disease. Electroencephalogr Clin Neurophysiol 1996; 110:443–447.

132.Yokoyama T, Suglyama K, Nishizawa S, Yokota N, Ohta S, Uemura K. Visual evoked potentials during posteroventral pallidotomy for Parkinson’s disease. Neurosurgery 1999; 44:815–822.

133.Tobimatsu S, Shima F, Ishido K, Kato M. Visual evoked potentials in the vicinity of the optic tract during stereotactic pallidotomy. Electroencephalogr Clin Neurophysiol 1997; 104:274–279.

134.De Meirleir LJ, Taylor MJ, Logan WJ. Multimodal evoked potentials studies in leukodystrophies of children. Can J Neurol Sci 1988; 15:26–31.

135.Markland ON, Garg BP, DeMyer WE, Warren C, Worth RM. Brain stem auditory, visual and somatosensory evoked potentials in leukodystrophies. Electroencephalogr Clin Neurophysiol 1982; 54:39–48.

136.Wulff CH, Trojaborg W. Adult metachromatic leukodystrophy: neurophysiologic findings. Neurology 1985; 35: 1776–1778.

137.Mamoli B, Graf M, Toifl K. EEG, pattern-evoked potentials and nerve conduction velocity in a family with adrenoleuco-

dystrophy. Electroencephalogr Clin Neurophysiol 1979; 47:411–419.

138.Tobimatsu S, Fukui R, Kato M, Kobayashi T, Kuroiwa Y. Multimodality evoked potentials in patients and carriers with adrenoleukodystrophy and adrenomyeloneuropathy. Electroencephalogr Clin Neurophysiol 1985; 62:18–24.

139.Kaplan PW, Kruse B, Tusa RJ, Shankroff J, Rignani J, Moser HW. Visual system abnormalities in adrenomyeloneuropathy. Ann Neurol 1995; 37:550–552.

140.Kaplan PW, Tusa RJ, Shankroff J, Heller J, Moser HW. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil. Ann Neurol 1993; 34:169–174.

141.Hood DC, Greenstein VC, Odel JG, Zhang X, Ritch R, Liebmann JM, Chen CS, Thienprasiddhi P. Visual field defects and multifocal visual evoked potentials: evidence of a linear relationship. Arch Ophthalmol 2002; 120:1672–1681.

142.Fortune B, Bearse MA, Cioffi GA, Johnson CA. Selective loss of an oscillatory component from temporal retinal multifocal ERG responses in glaucoma. Invest Ophthalmol Vis Sci 2002; 43:2638–2647.